ロード中...
Biomarkers and Surrogate Endpoints In Clinical Trials
One of the most important considerations in designing clinical trials is the choice of outcome measures. These outcome measures could be clinically meaningful endpoints that are direct measures of how patients feel, function and survive. Alternatively, indirect measures, such as biomarkers that incl...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2012
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3551627/ https://ncbi.nlm.nih.gov/pubmed/22711298 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/sim.5403 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|